Clinical trial Recruiting at 5 sites Interventional Ages 18 and up

Comparing drug-eluting stents and drug-coated balloons for coronary artery disease treatment

Official title: Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

Run by Deutsches Herzzentrum Muenchen · NCT05544864 · Data updated 2026-11-12

This study is testing whether drug-eluting stents or drug-coated balloons work better for patients with coronary artery disease who have had a previous stent and are experiencing symptoms again.

More Coronary Artery Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment376 (estimated)
SponsorDeutsches Herzzentrum Muenchen
Academic / other
Locations5 sites (Frankfurt am Main, Hesse and 4 other locations)
StatusRecruiting
StartedSeptember 28, 2022
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedJanuary 6, 2025
Trial IDNCT05544864 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with ischemic symptoms and at least 50% restenosis after prior drug-eluting stent placement.

Probably not a fit

Patients with acute myocardial infarction, severe renal insufficiency, or those requiring additional coronary interventions within 30 days may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of drug-eluting stents versus drug-coated balloons in patients experiencing restenosis after previous stent implantation. It focuses on the interaction between the morphology of neointima, as assessed by optical coherence tomography (OCT), and the type of intervention used. Patients with significant restenosis and ischemic symptoms will be randomized to receive either treatment, with the aim of determining which approach yields better outcomes based on neointima characteristics.

Why it matters

Potential benefit: If successful, this study could lead to more personalized and effective treatment options for patients with coronary artery disease and stent restenosis.

How similar studies have gone: Previous studies have shown varying success with drug-eluting stents and drug-coated balloons, but this specific approach based on neointima morphology is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with ischemic symptoms and/or evidence of myocardial ischemia
2. Presence of ≥ 50% restenosis after prior implantation of drug-eluting stents in native coronary vessels.
3. Availability of an OCT-pullback of the target lesion
4. Written informed consent by the patient for participation in the study.
5. Age ≥ 18 years

Exclusion Criteria:

1. Cardiogenic shock
2. Acute ST-elevation myocardial infarction within 48 hours from symptom onset.
3. Target lesion located in left main trunk or bypass graft.
4. Additional coronary intervention planned within 30 days of the procedure.
5. Non-successful treatment of other lesion(s) during the same procedure
6. Severe renal insufficiency (glomerular filtration rate ≤ 30 ml/min)
7. Contraindications to any components of the investigational devices or dual antiplatelet therapy
8. Pregnancy (present, suspected or planned) or positive pregnancy test.
9. Previous enrollment in this trial or participation in any other study at the time of enrollment.
10. Malignancies or other comorbid conditions with life expectancy less than 12 months or that may result in protocol non-compliance.
11. Patient's inability to fully comply with the study protocol

Where it's running

  • Universitätsklinikum Frankfurt
    Frankfurt am Main, Hesse, Germany
    Recruiting
  • Elisabeth-Krankenhaus Essen GmbH
    Essen, Germany
    Recruiting
  • Universitätsklinikum Hamburg-Eppendorf
    Hamburg, Germany
    Recruiting
  • Deutsches Herzzentrum München
    Munich, Germany
    Recruiting
  • Hospital Universitario de La Princesa Madrid
    Madrid, Madrid, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.